The efficasy of dexmedetomidine in preoperaive sleep

The efficasy of dexmedetomidine in preoperaive sleep - The efficasy of dexmedetomidine in preoperaive sleep

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032302

Enrollment

100

Registered

2018-04-20

Start date

2018-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder tumor, ureteral stones

Interventions

dexmedetomidine midazoram

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Over 20 years old 2)Patients undergoing urology surgery with spinal anesthesia 3)ASA-PS 1-2 4)Obtained written informed consent

Exclusion criteria

Exclusion criteria: 1 )ASA class >3. 2) Patient with the drug allergy 3) Pregnant woman, breast-feeding woman or possibility of pregnancy 4) constant user of sleep-inducing aganet 5) Judged as unsuitable for this study

Design outcomes

Primary

Measure	Time frame
the presence or absence of the use of sleep-inducing agent	—

Secondary

Measure	Time frame
patient's satisfaction	—

Countries

Japan

Contacts

Public ContactHiroe Takeda

Tokyo Rinkai Hospital Department of Anesthesiolgy

honaka@nms.ac.jp03-5605-8811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026